Business Context and Reporting Period
MGP Ingredients, Inc. (MGPI) filed a Form 8-K on August 6, 2026, reporting the entry into material definitive agreements regarding its credit facilities. The filing details amendments to the company's debt instruments to address specific financial covenant calculations related to accounts receivable losses and recent acquisition activities.
Key Financial Metrics and Debt Structure
- Debt Covenants: The company maintains a consolidated fixed charge coverage ratio covenant of not less than 1.25 to 1.00 and a consolidated net leverage ratio covenant of no greater than 4.00 to 1.00.
- Elevated Ratio Period: The net leverage ratio covenant may be increased to 4.50 to 1.00 during an "Elevated Ratio Period," which applies to the fiscal quarter ended June 30, 2026, and the three subsequent quarters.
- EBITDA Adjustment: Amendments permit the add-back of aggregate losses up to $20,000,000 related to specific accounts receivable for periods on or prior to December 31, 2027, to protect covenant compliance.
- Liquidity and Cash Flow: The filing does not provide specific values for revenue, profit, cash flow, or current liquidity positions.
Material Changes and Agreements
On August 6, 2026, the company executed two primary amendments:
- Amendment No. 2 to Credit Agreement: Modified the definition of Consolidated EBITDA to exclude up to $20 million in specific receivable losses from covenant calculations. This prevents uncollected receivables from negatively impacting the fixed charge coverage and net leverage ratios.
- Eighth Amendment to Note Purchase Agreement: Incorporated conforming changes to the Consolidated EBITDA definition for the Note Purchase and Private Shelf Agreement with PGIM, Inc. and affiliates.
These changes were implemented as precautionary measures and were supported by full participation from the banking group.
Outlook, Management Commentary, and Risks
Management Outlook: Management believes the third fiscal quarter of 2026 will represent the company's peak leverage, with expectations for leverage to decline thereafter. The Elevated Ratio Period was exercised in connection with earnout obligations for the acquisition of Penelope Bourbon LLC.
Risks and Contingencies:
- Inability to collect receivables.
- Failure to achieve expected improvements in the leverage position.
- Unanticipated costs or events arising from the amendments.
- Changes in lender relationships or credit facility terms.
- General economic and market conditions affecting liquidity and debt service ability.
Investor Verification Checklist
- Verify the specific customers associated with the up to $20 million in receivable losses permitted for EBITDA add-back.
- Confirm the actual leverage ratio for the quarter ended June 30, 2026, to assess proximity to the 4.50 to 1.00 threshold.
- Review the full text of Exhibit 10.1 and 10.2 for detailed terms of the amendments.
- Monitor future 10-Q filings to track the decline in leverage post-Q3 2026 as projected by management.
- Assess the status of earnout obligations related to the Penelope Bourbon LLC acquisition.